Surgery Partners Inc. (SGRY)
Surgery Partners Statistics
Share Statistics
Surgery Partners has 127.61M shares outstanding. The number of shares has increased by 0.41% in one year.
| Shares Outstanding | 127.61M |
| Shares Change (YoY) | 0.41% |
| Shares Change (QoQ) | 0.39% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 75.59M |
| Failed to Deliver (FTD) Shares | 34 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 10.19M, so 8.01% of the outstanding shares have been sold short.
| Short Interest | 10.19M |
| Short % of Shares Out | 8.01% |
| Short % of Float | 17.64% |
| Short Ratio (days to cover) | 14.34 |
Valuation Ratios
The PE ratio is -15.88 and the forward PE ratio is 15.48. Surgery Partners's PEG ratio is -0.01.
| PE Ratio | -15.88 |
| Forward PE | 15.48 |
| PS Ratio | 0.86 |
| Forward PS | 0.5 |
| PB Ratio | 1.49 |
| P/FCF Ratio | 12.73 |
| PEG Ratio | -0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Surgery Partners.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.79 |
| Quick Ratio | 1.65 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | 1.88 |
| Interest Coverage | 1.73 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $207.62K |
| Profits Per Employee | $-11.21K |
| Employee Count | 15,000 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 26.8 |
Taxes
| Income Tax | 134.6M |
| Effective Tax Rate | 91.5% |
Stock Price Statistics
The stock price has increased by -9.44% in the last 52 weeks. The beta is 2.4, so Surgery Partners's price volatility has been higher than the market average.
| Beta | 2.4 |
| 52-Week Price Change | -9.44% |
| 50-Day Moving Average | 23.82 |
| 200-Day Moving Average | 26.23 |
| Relative Strength Index (RSI) | 35.51 |
| Average Volume (20 Days) | 1.35M |
Income Statement
In the last 12 months, Surgery Partners had revenue of 3.11B and earned -168.1M in profits. Earnings per share was -1.33.
| Revenue | 3.11B |
| Gross Profit | 745.6M |
| Operating Income | 348.8M |
| Net Income | -168.1M |
| EBITDA | 501.4M |
| EBIT | 348.8M |
| Earnings Per Share (EPS) | -1.33 |
Balance Sheet
The company has 269.5M in cash and 393.5M in debt, giving a net cash position of -124M.
| Cash & Cash Equivalents | 269.5M |
| Total Debt | 393.5M |
| Net Cash | -124M |
| Retained Earnings | -737.3M |
| Total Assets | 7.89B |
| Working Capital | 495M |
Cash Flow
In the last 12 months, operating cash flow was 300.1M and capital expenditures -90.4M, giving a free cash flow of 209.7M.
| Operating Cash Flow | 300.1M |
| Capital Expenditures | -90.4M |
| Free Cash Flow | 209.7M |
| FCF Per Share | 1.66 |
Margins
Gross margin is 23.94%, with operating and profit margins of 11.2% and -5.4%.
| Gross Margin | 23.94% |
| Operating Margin | 11.2% |
| Pretax Margin | 4.72% |
| Profit Margin | -5.4% |
| EBITDA Margin | 16.1% |
| EBIT Margin | 11.2% |
| FCF Margin | 6.73% |
Dividends & Yields
SGRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for SGRY is $36, which is 69.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $36 |
| Price Target Difference | 69.7% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Scores
| Altman Z-Score | 1 |
| Piotroski F-Score | 5 |